Cargando…

Metabolic Reprogramming and Its Relationship to Survival in Hepatocellular Carcinoma

Hepatocarcinogenesis is frequently accompanied by substantial metabolic reprogramming to maximize the growth and proliferation of cancer cells. In this study, we carried out a comprehensive study of metabolomics and lipidomics profiles combined with gene expression analysis to characterize the metab...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qingqing, Tan, Yexiong, Jiang, Tianyi, Wang, Xiaolin, Li, Qi, Li, Yanli, Dong, Liwei, Liu, Xinyu, Xu, Guowang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997969/ https://www.ncbi.nlm.nih.gov/pubmed/35406630 http://dx.doi.org/10.3390/cells11071066

Ejemplares similares

Metabolic Reprogramming and Risk Stratification of Hepatocellular Carcinoma Studied by Using Gas Chromatography–Mass Spectrometry-Based Metabolomics
por: Fang, Chengnan, et al.
Publicado: (2022)

PNO1 inhibits autophagy-mediated ferroptosis by GSH metabolic reprogramming in hepatocellular carcinoma
por: Hu, Xiaomeng, et al.
Publicado: (2022)

Glutamine metabolic reprogramming in hepatocellular carcinoma
por: Ye, Yanyan, et al.
Publicado: (2023)

A Large‐scale, multicenter serum metabolite biomarker identification study for the early detection of hepatocellular carcinoma
por: Luo, Ping, et al.
Publicado: (2018)

Lipid Metabolic Reprogramming in Hepatocellular Carcinoma
por: Nakagawa, Hayato, et al.
Publicado: (2018)

Reprogramming of glucose metabolism in hepatocellular carcinoma: Progress and prospects
por: Shang, Run-Ze, et al.
Publicado: (2016)

URI alleviates tyrosine kinase inhibitors-induced ferroptosis by reprogramming lipid metabolism in p53 wild-type liver cancers
por: Ding, Zhiwen, et al.
Publicado: (2023)

Glucose metabolism reprogramming promotes immune escape of hepatocellular carcinoma cells
por: Zhang, Qiuyue, et al.
Publicado: (2023)

Quantitative proteomics by SWATH-MS reveals sophisticated metabolic reprogramming in hepatocellular carcinoma tissues
por: Gao, Yanyan, et al.
Publicado: (2017)

The role and mechanism of noncoding RNAs in regulation of metabolic reprogramming in hepatocellular carcinoma
por: Liao, Wenwei, et al.
Publicado: (2022)

Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
por: Jühling, Frank, et al.
Publicado: (2021)

Prognostic roles of metabolic reprogramming-associated genes in patients with hepatocellular carcinoma
por: Cui, Lijuan, et al.
Publicado: (2020)

Metabolic reprogramming of immune cells: Shaping the tumor microenvironment in hepatocellular carcinoma
por: Xia, Yujia, et al.
Publicado: (2021)

A20 suppresses hepatocellular carcinoma proliferation and metastasis through inhibition of Twist1 expression
por: Chen, Haiyang, et al.
Publicado: (2015)

Ezrin promotes hepatocellular carcinoma progression by modulating glycolytic reprogramming
por: Wang, Xinyue, et al.
Publicado: (2020)

Cuproptosis-related genes score: A predictor for hepatocellular carcinoma prognosis, immunotherapy efficacy, and metabolic reprogramming
por: Nie, Guilin, et al.
Publicado: (2023)

Metabolic Reprogramming of Sulfur in Hepatocellular Carcinoma and Sulfane Sulfur-Triggered Anti-Cancer Strategy
por: Zhang, Ximing, et al.
Publicado: (2020)

Making cancer fat: reprogramming of lipid metabolism by CD147 in hepatocellular carcinoma
por: Ju, Hye-Lim, et al.
Publicado: (2016)

Spatially resolved visualization of reprogrammed metabolism in hepatocellular carcinoma by mass spectrometry imaging
por: Ma, Bangzhen, et al.
Publicado: (2023)

Glucometabolic Reprogramming in the Hepatocellular Carcinoma Microenvironment: Cause and Effect
por: Tian, Huining, et al.
Publicado: (2020)

DNAJC24 is a potential therapeutic target in hepatocellular carcinoma through affecting ammonia metabolism
por: Li, Guangtao, et al.
Publicado: (2022)

Metabolic Reprogramming and Its Regulatory Mechanism in Sepsis-Mediated Inflammation
por: Liu, Wenzhang, et al.
Publicado: (2023)

The miR-125a/HK2 axis regulates cancer cell energy metabolism reprogramming in hepatocellular carcinoma
por: Jin, Fangfang, et al.
Publicado: (2017)

USP22 regulates lipidome accumulation by stabilizing PPARγ in hepatocellular carcinoma
por: Ning, Zhen, et al.
Publicado: (2022)

Growing Human Hepatocellular Tumors Undergo a Global Metabolic Reprogramming
por: Zhang, Fangrong, et al.
Publicado: (2021)

MFN1-dependent alteration of mitochondrial dynamics drives hepatocellular carcinoma metastasis by glucose metabolic reprogramming
por: Zhang, Ze, et al.
Publicado: (2019)

CD133/Prominin-1-Mediated Autophagy and Glucose Uptake Beneficial for Hepatoma Cell Survival
por: Chen, Haiyang, et al.
Publicado: (2013)

Metabolic Reprogramming in Thyroid Carcinoma
por: Coelho, Raquel Guimaraes, et al.
Publicado: (2018)

Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma
por: Zhao, Chuanzong, et al.
Publicado: (2020)

Wnt/β-Catenin Signaling as a Driver of Stemness and Metabolic Reprogramming in Hepatocellular Carcinoma
por: Leung, Rainbow Wing Hei, et al.
Publicado: (2022)

E3 ligase ZFP91 inhibits Hepatocellular Carcinoma Metabolism Reprogramming by regulating PKM splicing
por: Chen, De, et al.
Publicado: (2020)

Metabolic Reprogramming and Immune Evasion in Nasopharyngeal Carcinoma
por: Huang, Huimei, et al.
Publicado: (2021)

Glucometabolic reprogramming: From trigger to therapeutic target in hepatocellular carcinoma
por: Xia, Haoming, et al.
Publicado: (2022)

SMYD2 Promotes Hepatocellular Carcinoma Progression by Reprogramming Glutamine Metabolism via c-Myc/GLS1 Axis
por: Xu, Kangdi, et al.
Publicado: (2022)

Correction to: Loss of PTEN expression is associated with PI3K pathway-dependent metabolic reprogramming in hepatocellular carcinoma
por: Zhao, Chuanzong, et al.
Publicado: (2021)

Identification of Energy Metabolism Genes for the Prediction of Survival in Hepatocellular Carcinoma
por: Chen, Qinjunjie, et al.
Publicado: (2020)

Schistosoma japonicum Infection Leads to the Reprogramming of Glucose and Lipid Metabolism in the Colon of Mice
por: Yang, Xiaoying, et al.
Publicado: (2021)

Bulk and single-cell transcriptome profiling reveal extracellular matrix mechanical regulation of lipid metabolism reprograming through YAP/TEAD4/ACADL axis in hepatocellular carcinoma
por: Cai, Jingwei, et al.
Publicado: (2023)

S1PR1 induces metabolic reprogramming of ceramide in vascular endothelial cells, affecting hepatocellular carcinoma angiogenesis and progression
por: Wang, Xuehong, et al.
Publicado: (2022)

Metformin suppresses hypoxia-induced stabilization of HIF-1α through reprogramming of oxygen metabolism in hepatocellular carcinoma
por: Zhou, Xinke, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_onihiii9c7v8tiemfhhqgvvmq7